|
Market Closed -
Other stock markets
|
After hours 01:25:00 am | |||
| 31.92 SEK | -32.03% |
|
0.1820 | -99.43% |
| 11:03pm | Calendar Thursday, August 6 | FW |
| 15/06 | Immunovia Unveils New Data Ahead of Medicare Reimbursement Application | FW |
Company Valuation: Immunovia AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,697 | 595.2 | 92.66 | 152.7 | 122.4 | - | - |
| Change | - | -64.93% | - | 64.79% | -19.82% | - | - |
| Enterprise Value (EV) 1 | 1,443 | 526.7 | 92.66 | 76.09 | 55.43 | 48.43 | 104.4 |
| Change | - | -63.5% | - | -17.88% | -27.16% | -12.63% | 115.64% |
| P/E | -0.11x | -0.04x | -0.01x | -0.54x | -1.8x | -4.49x | -8.98x |
| PBR | 0.04x | 0.02x | - | - | - | - | - |
| PEG | - | -0.01x | - | 0x | 0x | 0.1x | 0.2x |
| Capitalization / Revenue | 1,775x | 494x | - | 203x | 38.3x | 7.08x | 2.23x |
| EV / Revenue | 1,510x | 437x | - | 101x | 17.3x | 2.8x | 1.9x |
| EV / EBITDA | -9.78x | -3.17x | - | -0.97x | -0.62x | -0.61x | -2.22x |
| EV / EBIT | -8.66x | -2.76x | - | -0.95x | -0.61x | -0.59x | -2.09x |
| EV / FCF | -9.27x | -2.97x | - | -0.91x | -0.59x | -0.56x | -1.86x |
| FCF Yield | -10.8% | -33.6% | - | -110% | -170% | -180% | -53.6% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -689 | -743 | -93 | -0.42 | -0.1 | -0.04 | -0.02 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 0.956 | 1.204 | - | 0.752 | 3.2 | 17.3 | 55 |
| EBITDA 1 | -147.6 | -166.2 | - | -78.06 | -89 | -80 | -47 |
| EBIT 1 | -166.6 | -191.2 | - | -80.38 | -91 | -82 | -50 |
| Net income 1 | -156 | -168.1 | -76.54 | -145.9 | -91 | -82 | -50 |
| Net Debt 1 | -254.1 | -68.47 | - | -76.6 | -67 | -74 | -18 |
| Reference price 2 | 75.0000 | 26.3000 | 0.5460 | 0.2270 | 0.1796 | 0.1796 | 0.1796 |
| Nbr of stocks (in thousands) | 22,632 | 22,632 | 169,711 | 672,667 | 672,667 | - | - |
| Announcement Date | 17/2/22 | 23/2/23 | 25/2/25 | 24/2/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 60.94x | 4.78x | 16.03x | 0.35% | 16.4B | ||
| 42.65x | - | - | 1.9% | 1.83B | ||
| -10.99x | 1.32x | 5.79x | -.--% | 1.2B | ||
| 16.43x | 2.32x | 7.77x | 1.43% | 984M | ||
| 53.38x | - | - | 0.84% | 547M | ||
| 53.2x | - | - | - | 521M | ||
| 18.99x | 2.68x | 11.46x | 1.79% | 393M | ||
| 25.52x | 4.34x | 14.79x | 1.85% | 372M | ||
| Average | 32.52x | 3.09x | 11.17x | 1.17% | 2.78B | |
| Weighted average by Cap. | 51.89x | 4.39x | 14.86x | 0.57% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IMMNOV Stock
- 0G8X Stock
- Valuation Immunovia AB
Select your edition
All financial news and data tailored to specific country editions
















